Journal of Diabetology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Short Communication - Journal of Diabetology (2024) Volume 8, Issue 4

What Future Innovations Can We Expect in Diabetes Therapies?

Corner leslier *

Department of Obstetrics and Gynaecology, McMaster University, Hamilton, Canada

*Corresponding Author:
Corner leslier
Department of Obstetrics and Gynaecology, McMaster University, Hamilton, Canada
E-mail: leslier@mmu.ca

Received: 08-Jun-2024, Manuscript No. . AADY-24-143982; Editor assigned: 10-Jun-2024, PreQC No. . AADY-24-143982 (PQ); Reviewed:24-Jun-2024, QC No. . AADY-24-143982; Revised:27-Jun-2024, Manuscript No. . AADY-24-143982 (R); Published: 04-Jul-2024, DOI:10.35841/aady -8.5.212

Citation: : Leslier C. Diabetes Management: An In-Depth Guide to Anti-Diabetic Medications, J Diabetol. 2024; 8(4):212

Visit for more related articles at Journal of Diabetology

Abstract

      

Introduction

Diabetes mellitus, commonly referred to as diabetes, is a chronic metabolic disorder characterized by elevated blood sugar levels. It is a global health concern affecting millions of people worldwide. To manage diabetes effectively, various treatment options are available, including lifestyle modifications, dietary changes, and, crucially, anti-diabetic agents. This article explores the essential role that anti-diabetic agents play in controlling blood sugar levels and improving the lives of individuals with diabetes [1].

Understanding diabetes

Before delving into the role of anti-diabetic agents, it's essential to understand the basics of diabetes. There are two main types of diabetes

Type 1 Diabetes: This autoimmune condition occurs when the body's immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. People with Type 1 diabetes require lifelong insulin therapy to regulate their blood sugar levels.

Type 2 Diabetes: This form of diabetes is characterized by insulin resistance, where the body's cells do not respond effectively to insulin. Over time, the pancreas may also produce less insulin. Initially, Type 2 diabetes can often be managed through lifestyle changes, such as diet and exercise. However, many individuals may eventually require medication [2, 3].

Role of anti-diabetic agents

Anti-diabetic agents, also known as diabetes medications or hypoglycemic agents, are pharmaceutical substances designed to lower blood sugar levels [3]. They are a crucial component of diabetes management and can be categorized into several classes, each with its unique mechanism of action:

  1. Insulin: For individuals with Type 1 diabetes or advanced Type 2 diabetes, insulin therapy is a lifesaving treatment. Insulin injections or pumps provide the body with the necessary hormone to regulate glucose uptake by cells and reduce blood sugar levels.
  2. Oral hypoglycaemic agents: These medications are commonly used for Type 2 diabetes and come in various classes, including sulfonylureas, biguanides, DPP-4 inhibitors, SGLT-2 inhibitors, and others. They work in different ways, such as increasing insulin production, reducing glucose production in the liver, or enhancing glucose uptake by cells [4-6].
  3. GLP-1 Receptor agonists: These drugs mimic the action of the hormone glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels by increasing insulin secretion and slowing down stomach emptying. GLP-1 receptor agonists are typically administered via injections.
  4. Amylin analogs: Amylin is a hormone that helps control blood sugar levels by slowing down digestion and reducing post-meal glucose spikes. Amylin analogs, such as pramlintide, can be used alongside insulin therapy to improve blood sugar control.
  5. Combination therapies: In some cases, healthcare providers may prescribe a combination of anti-diabetic agents to address multiple aspects of blood sugar regulation simultaneously [7, 8].
  6. Controlling blood sugar levels:The primary goal of anti-diabetic agents is to maintain blood sugar levels within a target range to prevent short-term and long-term complications of diabetes. By achieving this goal, individuals with diabetes can:
  7. Prevent hyperglycemia: Hyperglycemia, or high blood sugar, can lead to symptoms like increased thirst, frequent urination, and fatigue. It can also cause severe complications over time, including cardiovascular disease, kidney damage, and nerve problems.
  8. Minimize hypoglycemia: Hypoglycemia, or low blood sugar, can result from an excessive dose of anti-diabetic medication, inadequate food intake, or excessive physical activity. It can lead to symptoms like shakiness, dizziness, confusion, and, in severe cases, loss of consciousness. The proper selection and dosage of anti-diabetic agents help minimize the risk of hypoglycemia.
  9. Improve quality of life: Well-managed blood sugar levels enable individuals with diabetes to lead healthier and more active lives. By preventing extreme fluctuations in blood sugar, anti-diabetic agents contribute to a better quality of life and reduced diabetes-related complications [9, 10].

References

Gambini J, Inglés M, Olaso Get al. Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. 2015;2015.

Indexed at, Google Scholar, Cross Ref

Koushki M, Amiri?Dashatan N, Ahmadi N, et al. Resveratrol: A miraculous natural compound for diseases treatment. Food Sci Nutr. 2018;6(8):2473-90.

Indexed at, Google Scholar, Cross Ref

Pignet AL, Schellnegger M, Hecker A, et al. Resveratrol-induced signal transduction in wound healing. Int J Mol Sci. 2021;22(23):12614.

Indexed at, Google Scholar, Cross Ref

Kumari A, Raina N, Wahi A, et al. Wound-Healing Effects of Curcumin and Its Nanoformulations: A Comprehensive Review. Pharmaceutics. 2022;14(11):2288.

Indexed at, Google Scholar, Cross Ref

Prasad S, Aggarwal BB. Turmeric, the golden spice. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. 2011.

Google Scholar

Salehi B, Fokou PV, Sharifi-Rad M, et al. The therapeutic potential of naringenin: a review of clinical trials. Pharmaceuticals. 2019;12(1):11.

Indexed at, Google Scholar, Cross Ref

Sun R, Liu C, Liu J, et al. Integrated network pharmacology and experimental validation to explore the mechanisms underlying naringenin treatment of chronic wounds. Scientific Reports. 2023;13(1):132.

Indexed at, Google Scholar, Cross Ref

Diniz LR, Calado LL, Duarte AB, et al. Centella asiatica and Its Metabolite Asiatic Acid: Wound Healing Effects and Therapeutic Potential. Metabolites. 2023;13(2):276.

Indexed at, Google Scholar, Cross Ref

Morissette M, Litim N, Di Paolo T. Natural phytoestrogens: A class of promising neuroprotective agents for Parkinson disease. InDiscovery and Development of Neuroprotective Agents from Natural Products 2018 (pp. 9-61). Elsevier.

Indexed at, Google Scholar, Cross Ref

Lan X, Wang W, Li Q, et al. The natural flavonoid pinocembrin: molecular targets and potential therapeutic applications. Mol Neurobiol. 2016;53:1794-801.

Indexed at, Google Scholar, Cross Ref

Get the App